Pfizer, Incorporated
235 East 42nd Street New York, NY 10017
Phone: (212) 573-2323
Web Site: www.pfizer.com
Industry: Drugs Sector: Healthcare
Employees: 106,000
Stock Symbol: PFE

Business Summary: Pfizer Inc. was incorporated under the laws of the State of Delaware on June 2, 1942. Pfizer Inc. is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals as well as many of the world's known consumer healthcare products. Since 2000 the Company has been into acquisitions. The Company operates in three business segments: Human Health, Consumer Healthcare and Animal Health. Human Health business is the pharmaceutical business in the world. This segment includes treatments for cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye disease, endocrine disorders and allergies. The Company's principal pharmaceutical products and certain recently approved products which are used in following diseases: Cardiovascular and Metabolic Diseases, Central Nervous System Disorders, Arthritis and Pain, Infectious and Respiratory Diseases, Urology, Oncology and Ophthalmology. Their Consumer Healthcare business market many of the OTC, or self-medications, for oral care, upper respiratory health, tobacco dependence, gastrointestinal health, skin care, eye care and hair growth. Consumer Healthcare's principal products includes, Listerine mouthwash, Listerine PocketPaks oral care strips, Nicorette for tobacco dependence, Benadryl antihistamine for allergies, Sudafed for sinus congestion, Rogaine for hair growth, Zantac for prevention and relief of heartburn, Rolaids antacid tablets. Neosporin antibiotic ointment, Visine eye drops, Lubriderm moisturizing lotions, Purell instant hand sanitizer. Consumer Healthcare can extend the life of some of Pfizer's prescription medications by converting them to OTC products. For example, Nicorette, Benadryl, Sudafed and Zantac were all previously prescription products. As market conditions permit, and when the Company has necessary approval from drug regulatory authorities, the Company plans to pursue similar launches for other products. The Company's Animal Health business includes development and sales of those products for the prevention and treatment of diseases in livestock and companion animals. Parasiticides constitute the largest segment of the animal health market for companion animals, consisting mainly of medicines for the control of parasites such as fleas and heartworm. Their product, Revolution, is selling parasiticide for companion animals. Spectramast, an antibiotic formulated to treat clinical mastitis, they launched in the U.S. in May 2005. Rimadyl relieves pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery. Rimadyl is the only arthritis pain medication prescribed by veterinarians available in chewable tablets, regular caplets and in an injectable formulation. Clavamox/Synulox is an antibiotic for skin and soft tissue infections in dogs and cats. Pfizer's vaccine portfolio for livestock includes RespiSureOne/StellamuneOne, a single-dose vaccine used to prevent pneumonia in swine, and Bovi-Shield Gold, a cattle vaccine for reproductive and respiratory protection. Dectomax injectable and pour-on formulations remove and control internal and external parasites in beef cattle. Naxcel RTU is an antibiotic used to treat respiratory and internal infections in cattle and swine. As of December 31, 2005, Company employed approximately 106,000 people in their operations throughout the world. Officers: Jeffrey B. Kindler , CEO